Does TOFACITINIB Cause Swollen joint count increased? 1,753 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,753 reports of Swollen joint count increased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 1.1% of all adverse event reports for TOFACITINIB.
1,753
Reports of Swollen joint count increased with TOFACITINIB
1.1%
of all TOFACITINIB reports
894
Deaths
975
Hospitalizations
How Dangerous Is Swollen joint count increased From TOFACITINIB?
Of the 1,753 reports, 894 (51.0%) resulted in death, 975 (55.6%) required hospitalization, and 1,053 (60.1%) were considered life-threatening.
Is Swollen joint count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,753 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Swollen joint count increased?
METHOTREXATE (2,068)
ABATACEPT (2,032)
TOCILIZUMAB (1,987)
RITUXIMAB (1,973)
ADALIMUMAB (1,933)
DICLOFENAC (1,916)
LEFLUNOMIDE (1,907)
FOLIC ACID (1,898)
PREDNISONE (1,882)
ALENDRONATE (1,880)
Which TOFACITINIB Alternatives Have Lower Swollen joint count increased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN